How can CoPARC help you?

  • Translational research support in the area of alcohol abuse/dependence
  • Clinical research support in the area of alcohol abuse/dependence
  • Biorepository of human participants’ specimens and data
  • Focus on respiratory- or pulmonary-related disease, but consideration for investigations in other organ systems
  • Exploratory investigations related to other substances commonly consumed with alcohol, including tobacco and cannabis


Member Login

REDCap

Welcome to CoPARC

CoPARC LOGOThe Colorado Pulmonary - Alcohol Research Collaborative (CoPARC) focuses on investigations in the pathogenesis and treatment of pulmonary (respiratory) diseases associated with alcohol use disorders (AUDs). CoPARC investigators seek to identify alcohol-related defects in pulmonary host defense. We believe that AUDs, with or without smoking, negatively impact the pulmonary immune response, rendering individuals more susceptible to bacterial pneumonia and the acute respiratory distress syndrome. We are also interested in considering the superimposed respiratory effects of tobacco and cannabis that are commonly consumed by people with AUDs. Mechanisms defined in healthy participants with AUDs will be further explored in cohorts of critically ill patients to determine their impact on clinical outcomes and to tailor therapy. 

The CoPARC infrastructure at the University of Colorado has supported enrollment of participants with AUDs and matched controls, and critically ill patients who have respiratory failure, some who have sustained burn injuries. Detailed information regarding alcohol consumption habits, along with tobacco and cannabis use are obtained on all participants. Since 2011, an interactive environment has been developed between institutions with a history of NIAAA-funded translational research in pulmonary diseases, fostering growth of novel investigations, and providing opportunities for career development.

Upcoming Events


American Thoracic Society International Meeting, May 15-20, 2020. Philadelphia, PA. 

Thomas L. Petty Aspen Lung Conference, 63rd Annual Meeting, June 10-13, 2020. Aspen, CO.

43rd Annual RSA Scientific Meeting / ISBRA Congress, June 20-24, 2020, New Orleans, LA

Alcohol and Immunology Research Interest Group (AIRIG) Meeting, Loyola University Chicago, November 2020, Chicago, IL.

News & Media


Ethics of Health Research Supported by For-Profit Cannabis Companies: What Have We Learned from Big Tobacco?

Legal Marijuana Industry Grows Amid Unanswered Questions for Public Health.

​1 in 7 US adults use marijuana​.​​​See Dr. Burnham and Dr. Hua’s perspective for Healio.com.

CoPARC was profiled in Dean Traystman’s (Vice Chancellor for Research at UCD) research tips newsletter

Colorado Pulmonary-Alcohol Research Consortium (CoPARC) Funding

This website and the research reported here is supported by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under award number R24AA019661.

Additional support is provided by the Colorado Clinical and Translational Sciences Institute on the University of Colorado Anschutz Medical Campus, funded by NIH/NCATS award number UL1TR001082.

The Thoracic Foundation #AWD161639

Contact Us

Email CoPARC
CoPARC@cuanschutz.edu

CoPARC Director
Ellen.Burnham@cuanschutz.edu

Resource Questions
Jeanette.Gaydos@cuanschutz.edu